Ghassan Abu-Sittah: GMC Appeal After Antisemitism Allegations Dismissed

A UK surgeon, Dr. Ghassan Abu-Sittah, cleared of misconduct allegations by a medical tribunal, has publicly criticised his regulatory body, the General Medical Council (GMC), for appealing the decision. The case, initially brought following a complaint by the pro-Israel advocacy group UK Lawyers for Israel (UKLFI), centered on claims of antisemitism and support for terrorism stemming from a newspaper article and social media posts. Dr. Abu-Sittah, a reconstructive plastic surgery consultant and rector of the University of Glasgow, now faces the prospect of further legal battles and has launched a crowdfunding campaign to cover anticipated costs.

The Initial Allegations and Tribunal Findings

The complaint against Dr. Abu-Sittah, lodged by UKLFI, focused on an article published in the Lebanese newspaper Al Akhbar and two reposts on X (formerly Twitter). UKLFI alleged these actions “impaired his fitness to practise” medicine. The case underwent multiple stages, beginning with an Interim Orders Tribunal (IOT) which found no evidence to suggest a risk to patient safety. In fact, the IOT acknowledged the “exceptional testimonials” submitted in Dr. Abu-Sittah’s defense. A subsequent full hearing at the Medical Practitioners Tribunal Service (MPTS) ultimately cleared him of any wrongdoing in January 2026. The MPTS panel, chaired by Ian Comfort, explicitly stated they did not find anything in the article that was antisemitic or supportive of violence or terrorism, considering the text in its entirety. Similarly, the reposted tweets relating to Hamas and the Popular Front for the Liberation of Palestine were not deemed to incite or support violence.

GMC Appeal and Concerns of Political Influence

Despite the MPTS’s clear ruling, the GMC announced its intention to appeal the decision to the High Court. This move has prompted Dr. Abu-Sittah to accuse the GMC of being influenced by political pressure, stating that the regulator appears to be pursuing a “politically acceptable” outcome. He believes the ongoing legal challenges are an attempt to discredit his professional and humanitarian work, including his testimony before the International Criminal Court (ICC) and the International Court of Justice (ICJ) regarding Israel’s actions in Gaza. He has voiced concerns about the financial burden of the appeal, which will be borne by GMC members through fees.

Dr. Abu-Sittah’s concerns are echoed by the fact that the GMC is set to lose its right to appeal its own tribunal decisions later in 2026. Charlie Massey, the GMC’s chief executive, acknowledged this change during a parliamentary committee hearing in January, stating the regulator was “reconciled to” the loss of appeal rights. A 2018 review had previously highlighted a perception that the GMC had “two opportunities to make its case” – initially at the MPTS and then through an appeal if dissatisfied with the outcome.

Broader Context: UKLFI’s Role and the Professional Standards Authority

Whereas the GMC is pursuing the appeal, UKLFI maintains it had no direct involvement in the decision. However, the group has lodged its own complaint with the Professional Standards Authority regarding the GMC’s handling of the case and the MPTS’s ruling. UKLFI alleges the GMC failed to present all relevant evidence to the tribunal concerning Dr. Abu-Sittah’s past actions, specifically regarding his commemoration and support of organizations considered terrorist groups.

The Impact on Dr. Abu-Sittah and the Wider Implications

The protracted legal battle has taken a significant toll on Dr. Abu-Sittah, causing both mental and financial strain. He reports receiving an “outpouring of support” from colleagues, patients, and even Israeli co-workers who submitted testimonials to the GMC tribunals. However, the ongoing proceedings continue to cast a shadow over his professional life and advocacy work. The case raises broader questions about the potential for political interference in the regulation of medical professionals and the fairness of disciplinary processes. The GMC maintains that its decision to appeal was made carefully and is based on its primary duty to protect the public, given the nature of the allegations.

What Comes Next: Legal Challenges and Regulatory Changes

Dr. Abu-Sittah is currently crowdfunding to raise £150,000 to cover the legal costs associated with defending himself against the GMC’s appeal. The appeal process itself will likely take several months, with hearings expected at the High Court. Simultaneously, the GMC is preparing to relinquish its right to appeal MPTS decisions, a change that is expected to streamline the disciplinary process and reduce the potential for protracted legal battles. The outcome of both the appeal and the regulatory changes will have significant implications for the future of medical regulation in the UK and the handling of similar cases involving politically sensitive issues. Further updates on the case can be found on the International Centre for Justice for Palestinians website: https://www.icjpalestine.com/ and Middle East Eye: https://www.middleeasteye.net/news/uk-medical-regulator-appeal-decision-clearing-palestinian-surgeon-ghassan-abu-sittah. The GMC’s official statements and updates on regulatory changes are available on their website: https://www.gmc-uk.org/.